| Financial Year |
March 31 2023 |
| Monetary Funds |
200,358,672.77 |
| Held-for-trading Financial Assets |
297,565,774.12 |
| Notes Receivable |
4,066,912.32 |
| Accounts Receivable |
181,475,939.92 |
| Advances to Suppliers |
30,739,285.79 |
| Other Receivables |
46,877,912.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
22,437,595.24 |
| Inventories |
177,692,054.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,573,939.61 |
| Total Current Assets |
953,207,882.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
280,467,366.96 |
| Investment Properties |
41,264,641.51 |
| Fixed Assetes |
208,542,407.72 |
| Under-construction Projects |
75,675,517.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
590,672,928.51 |
| R&D expenses |
17,839,499.72 |
| Goodwill |
146,008,432.08 |
| Long-Term Deferred and Prepaid Expenses |
611,943.53 |
| Deferred Income Tax Assets |
38,437,223.99 |
| Other Non-Current Assets |
11,914,143.15 |
| Sub-Total of Non-Current Assets |
1,660,407,015.68 |
| Total Assets |
2,613,614,898.59 |
| Short-Term Loans |
441,094,988.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,249,318.65 |
| Accounts Payable |
93,532,396.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,278,867.22 |
| Taxes Payable |
9,896,162.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,384,980.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
123,020,041.74 |
| Other Current Liabilities |
6,619,750.71 |
| Sub-Total of Current Liabilities |
815,103,333.60 |
| Long-term Loans |
172,788,353.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
175,274,626.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
366,118,324.85 |
| Total Liabilities |
1,181,221,658.45 |
| Paid-In Capital(Or Share Stock) |
739,757,400.00 |
| Capital Surplus |
339,732,427.42 |
| Surplus Reserve |
145,724,697.13 |
| LESS:Treasury Stock |
63,985,339.93 |
| Undistributed Profits |
264,979,464.14 |
| Minority Stockholder's Interest |
-4,204,427.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,436,597,667.95 |
| Owner's Equity（Stockholder's Equity） |
1,432,393,240.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,613,614,898.59 |
